Search Results 81-90 of 17294 for hba1c

  1. A Study to Evaluate the Relationship of the Glucose Threshold for Insulin Secretion with Beta-cell Function - Mayo Clinic

    HbA1c ≥ 6.5%. Use of glucose-lowering agents. For female subjects: positive pregnancy test at the time of enrollment or study. History of prior upper ...

  2. Insulin and weight gain: Keep the pounds off - Mayo Clinic

    Understand why weight gain is linked to insulin treatment, and find out how to dodge those extra pounds while still managing your blood sugar.

  3. INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes - Mayo Clinic

    Participation eligibility · Same treatment regimen (MDI, an AID system, or an insulin pump without automation) for the 3 months prior to screening: · HbA1c < 11.0 ...

  4. SPI-62 As A Treatment For Adrenocorticotropic Hormone-dependent Cushing’s Syndrome - Mayo Clinic

    Insulin-resistance may also be defined by abnormal HOMA-IR < 2.5 or by CGM data (e.g., mean glucose, glycemic variability, time in range, estimated HbA1c).

  5. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

    mellitus defined as HbA1c ≥8% during Screening. - Treatment with another investigational drug (including investigational drugs for ALS through ...

  6. A Study to Evaluate Direct Measurement of Proinsulin Clearance in Humans - Mayo Clinic

    HbA1c ≥ 6.5%. Use of glucose-lowering agents. For female subjects: positive pregnancy test at the time of enrollment or study. History of prior upper ...

  7. Insulin and Insulin Pulses on Fasting Glucagon Secretion and on Glucose Metabolism in Subjects Without Type 2 Diabetes - Mayo Clinic

    HbA1c ³ 6.5%. Use of any glucose-lowering agents including metformin or sulfonylureas. For female subjects: positive pregnancy test at the time of ...

  8. A Study To Evaluate The Safety And Effectiveness Of Obeticholic Acid Treatment On People With Non-Alcoholic Steatohepatitis With Fibrosis - Mayo Clinic

    HbA1c > 9.5% within 60 days before Day 1. Evidence of other forms of known chronic liver disease including: Positive test result at Screening for hepatitis ...

  9. A Study to Evaluate the Effect of Fasting Free Fatty Acids and Fasting Glucose on Postprandial Glucose Metabolism - Mayo Clinic

    HbA1c ≥ 6.5%. Use of glucose-lowering agents. For female subjects, positive pregnancy test at the time of enrollment or study. History of prior upper ...

  10. Effect Of TAK-954 On Gastrointestinal And Colonic Transit In Diabetic Or Idiopathic Gastroparesis Participants - Mayo Clinic

    Have glycosylated hemoglobin (HbA1c) greater than (>) 12 percent (%). Have other structural diseases/conditions that affect the gastrointestinal (GI) system ...